Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $482.74 million. The enterprise value is $180.75 million.

Market Cap	482.74M
Enterprise Value	180.75M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CGEM has 59.01 million shares outstanding. The number of shares has increased by 37.06% in one year.

Current Share Class	59.01M
Shares Outstanding	59.01M
Shares Change (YoY)	+37.06%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	3.99%
Owned by Institutions (%)	81.42%
Float	39.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.87
P/TBV Ratio	0.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.00.

Current Ratio	11.62
Quick Ratio	11.11
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.57% and return on invested capital (ROIC) is -26.58%.

Return on Equity (ROE)	-36.57%
Return on Assets (ROA)	-25.38%
Return on Invested Capital (ROIC)	-26.58%
Return on Capital Employed (ROCE)	-37.83%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	111
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CGEM has paid $117,000 in taxes.

Income Tax	117,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.72% in the last 52 weeks. The beta is -0.08, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-59.72%
50-Day Moving Average	8.05
200-Day Moving Average	10.34
Relative Strength Index (RSI)	54.88
Average Volume (20 Days)	331,311

Short Selling Information

The latest short interest is 5.88 million, so 9.97% of the outstanding shares have been sold short.

Short Interest	5.88M
Short Previous Month	5.99M
Short % of Shares Out	9.97%
Short % of Float	15.09%
Short Ratio (days to cover)	16.25

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-208.93M
Pretax Income	-156.28M
Net Income	-178.74M
EBITDA	-208.62M
EBIT	-208.93M
Earnings Per Share (EPS)	-$3.10

Balance Sheet

The company has $303.83 million in cash and $1.84 million in debt, giving a net cash position of $301.99 million or $5.12 per share.

Cash & Cash Equivalents	303.83M
Total Debt	1.84M
Net Cash	301.99M
Net Cash Per Share	$5.12
Equity (Book Value)	551.84M
Book Value Per Share	9.40
Working Capital	290.42M

Cash Flow

Operating Cash Flow	-150.21M
Capital Expenditures	n/a
Free Cash Flow	-150.21M
FCF Per Share	-$2.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.06%
Shareholder Yield	-37.06%
Earnings Yield	-37.03%
FCF Yield	-31.12%

Analyst Forecast

The average price target for CGEM is $28.17, which is 244.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.17
Price Target Difference	244.38%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1